Stay updated on Pediatric Ph+ CML Clinical Trial.
Sign up to get notified when there's something new on the Pediatric Ph+ CML Clinical Trial. page.

Latest updates to the Pediatric Ph+ CML Clinical Trial. page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.2%
- Check15 days agoChange DetectedDifference0.3%
- Check22 days agoChange DetectedThe page has undergone significant changes, including the removal of detailed information about a clinical study on nilotinib for pediatric patients with Ph+ chronic myelogenous leukemia, while a new version number has been added.SummaryDifference12%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.3%
- Check37 days agoChange DetectedThe page has been updated to include information on Chronic Myeloproliferative Disorders and has revised its version number to v2.14.3, while removing references to Chronic Graft Versus Host Disease and the previous version v2.14.2.SummaryDifference0.2%
- Check44 days agoChange DetectedDifference0.3%
Stay in the know with updates to Pediatric Ph+ CML Clinical Trial.
Enter your email address, and we'll notify you when there's something new on the Pediatric Ph+ CML Clinical Trial. page.